Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Classical pathway complement activity in schizophrenia.

Svetlana Hakobyan1, Anna Boyajyan, Robert B Sim

  • 1Institute of Molecular Biology NAS RA, 7 Hasratyan St, 375014 Yerevan, Armenia.

Neuroscience Letters
|January 6, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complement-Coagulation Cross-talk: Factor H-mediated regulation of the Complement Classical Pathway activation by fibrin clots.

Frontiers in immunology·2024
Same author

Complement Activation-Independent Attenuation of SARS-CoV-2 Infection by C1q and C4b-Binding Protein.

Viruses·2023
Same author

l-ficolin-MASP arm of the complement system in schizophrenia.

Immunobiology·2023
Same author

Fusarium verticillioides NAT1 (FDB2) N-malonyltransferase is structurally, functionally and phylogenetically distinct from its N-acetyltransferase (NAT) homologues.

The FEBS journal·2022
Same author

Human Properdin Released By Infiltrating Neutrophils Can Modulate Influenza A Virus Infection.

Frontiers in immunology·2021
Same author

C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and Outcomes.

Clinical journal of the American Society of Nephrology : CJASN·2021
Same journal

Dynorphinergic neuroadaptations in the islands of Calleja: implications for alcohol use disorder.

Neuroscience letters·2026
Same journal

Differential vulnerability of cochlear nuclei to Lmx1 deficiency: abnormal patterning and implications for auditory circuitry.

Neuroscience letters·2026
Same journal

Role of nNOS/sGC pathway in the insular cortex in control of cardiovascular, autonomic and corticosterone responses to restraint stress in rats.

Neuroscience letters·2026
Same journal

Jak1 inhibition reduces acute allodynia induced by specific upstream cytokines in rats: implications for the onset of Jak1 pain modulation.

Neuroscience letters·2026
Same journal

Glucocorticoids-induced depressive-like behaviors in mice: oral ingestion of corticosterone or hydrocortisone - A comparative study.

Neuroscience letters·2026
Same journal

Data-driven clustering of prefrontal activation identifies functional phenotypes under prioritized dual-task walking conditions in Parkinson's disease.

Neuroscience letters·2026
See all related articles

Schizophrenia pathogenesis may involve complement system alterations. Specifically, complement components C1, C3, and C4 showed higher activity, while C2 activity was lower in patients compared to healthy individuals.

Area of Science:

  • Neuroimmunology
  • Complement System Biology

Background:

  • The role of the complement system in schizophrenia pathogenesis is suggested but conflicting.
  • Classical pathway complement activity data in schizophrenia patients are inconsistent.

Purpose of the Study:

  • To investigate the hemolytic activities of complement and its classical pathway components (C1, C2, C3, C4) in schizophrenia patients.
  • To compare complement activity between schizophrenia patients with a positive family history and healthy controls.

Main Methods:

  • Serum samples from schizophrenia patients and healthy subjects were analyzed.
  • Total hemolytic complement activity and individual component activities (C1, C2, C3, C4) were measured.

Main Results:

  • Significantly higher hemolytic activity for complement components C1, C3, and C4 in schizophrenia patients compared to controls.

Related Experiment Videos

  • Significantly lower hemolytic activity for complement component C2 in schizophrenia patients.
  • No significant difference in total hemolytic complement activity between patient and control groups.
  • C3 hemolytic activity was 2.17 times higher in medicated patients than in drug-free patients.

    • Conclusions:

    • Schizophrenia pathogenesis is associated with altered activities of classical pathway complement components.
    • Specific complement component dysregulation, not total activity, may be relevant in schizophrenia.